Results 31 to 40 of about 1,018 (169)

TAFRO Syndrome Without Pathology Supporting Castleman Disease: To Be Treated as Idiopathic Multicentric Castleman Disease-TAFRO or a Distinct Disease Entity? [PDF]

Turkish Journal of Hematology
Objective: TAFRO syndrome, entailing thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly, was previously considered a subtype of idiopathic multicentric Castleman disease (iMCD-TAFRO), with the diagnosis requiring pathology supporting
Siyuan Li, Yuhan Gao, Yue Dang, Lu Zhang, Jian Li   +4 more
doaj   +2 more sources

TAFRO syndrome associated with C3 nephropathy (an analysis of clinical experience) [PDF]

Klinicist
Aim. To present a clinical case of TAFRO syndrome – a recently described subtype of idiopathic multicentric Castleman disease of unknown etiology, characterized by thrombocytopenia, anasarca, fever, reticulin fibrosis of the bone marrow and / or renal ...
I. V. Pozharov, A. O. Grigorevskaya, G. R. Setdikova, E. S. Stolyarevich   +3 more
doaj   +3 more sources

Castleman disease and TAFRO syndrome. [PDF]

Ann Hematol, 2022
Although Castleman disease was first described in 1956, this disease includes various conditions, including unicentric Castleman disease with hyaline vascular histology, human herpesvirus-8 (HHV-8) related multicentric Castleman disease, idiopathic multicentric Castleman disease, and mimics of Castleman disease associated with other conditions. To date,
Masaki Y, Arita K, Sakai T, Takai K, Aoki S, Kawabata H.   +5 more
europepmc   +4 more sources

Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease [PDF]

, 2021
Thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly (TAFRO) syndrome is a heterogeneous entity manifesting with a constellation of symptoms described above that can occur in the context of idiopathic multicentric ...
Fajgenbaum, David C., Iwaki, Noriko, Izutsu, Koji, Kawano, Mitsuhiro, Maeda, Yoshinobu, Nakamura, Naoya, Nishikori, Asami, Nishimura, Midori Filiz, Nishimura, Yoshito, Oksenhendler, Eric, Otsuka, Fumio, Pierson, Sheila K., Sato, Yasuharu, Takeuchi, Kengo, van Rhee, Frits, Yoshizaki, Kazuyuki   +15 more
core   +1 more source

Historical and pathological overview of Castleman disease [PDF]

, 2022
Castleman disease consists of several lymphoproliferative subtypes that share some histological features in the lymph nodes. On the other hand, numerous clinical findings and etiologies make the disease challenging to understand.
Nishikori, Asami, Nishimura, Midori Filiz, Nishimura, Yoshito, Sato, Yasuharu, Yoshino, Tadashi   +4 more
core   +1 more source

TAFRO syndrome: current perspectives [PDF]

Journal of Blood Medicine, 2018
Multicentric Castleman's disease (MCD), a distinct subtype of Castleman's disease, is a rare, nonneoplastic, lymphoproliferative disorder. Patients with MCD present with systemic symptoms and multiple lymphadenopathy. Lymph node biopsy is necessary for the diagnosis of various histological MCD patterns including hyaline vascular, plasma cell, and mixed
Kentaro Sakashita, Kengo Murata, Mikio Takamori   +2 more
core   +6 more sources

Abnormal Exacerbation of Moderately Differentiated Gastric Adenocarcinoma in a Patient with TAFRO Syndrome: An Impaired Tumor Immunity?

Case Reports in Oncology, 2022
TAFRO syndrome is a relatively new disease entity first reported in 2010. We report a case of TAFRO syndrome accommodated by abnormal exacerbation of moderately differentiated gastric adenocarcinoma.
Tadaaki Inano, Hajime Yasuda, Yutaka Tsukune, Miyuki Tsutsui, Nadila Wali, Harumi Saeki, Kazunori Kajino, Okio Hino, Yasufumi Masaki, Norio Komatsu   +9 more
doaj   +1 more source

Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease? [PDF]

, 2022
Idiopathic multicentric Castleman disease (iMCD) is a systemic disorder characterized by systemic inflammation and organ dysfunction associated with an increase in pro-inflammatory cytokines.
Czech, Torrey, Mizuno, Hiroki, Momose, Shuji, Nishikori, Asami, Nishimura, Midori Filiz, Nishimura, Yoshito, Ohsawa, Kumiko, Otsuka, Fumio, Otsuka, Yuki, Sato, Yasuharu, Sawa, Naoki, Sawada, Haruki   +11 more
core   +1 more source

Delayed diagnosis of TAFRO syndrome: A case report. [PDF]

Medicine (Baltimore)
Rationale: TAFRO syndrome is a systemic inflammatory disorder, manifesting as thrombocytopenia (t), anasarca (a), fever (f), reticulin myelofibrosis/renal insufficiency (r), and organomegaly (o), and considered as a unique clinical subtype of idiopathic multicentric Castleman disease (iMCD).
Qiao Y, Zhang X, Xu R, Jia X, Wang Q.
europepmc   +3 more sources

TAFRO Syndrome: A Disease Requiring Immediate Medical Attention. [PDF]

Intern Med, 2023
TAFRO syndrome was first described in 2010, standing for thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly. Because the lymph node histopathology of TAFRO syndrome mimics idiopathic multicentric Castleman disease (iMCD), some researchers consider TAFRO syndrome to be a subtype of iMCD.
Masaki Y, Ueda Y, Yanagisawa H, Arita K, Sakai T, Yamada K, Mizuta S, Fukushima T, Takai K, Aoki S, Kawabata H.   +10 more
europepmc   +3 more sources